Not logged in Share Save
Share Save
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC) Lemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology-based combinations Mcgregor, Bradley A.; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta Share Save
Exploring Health-Related quality of life across the disease spectrum in renal cell carcinoma: a conceptual domain analysis Shah, Koral; Bergerot, Paulo Gustavo; Castro, Daniela; Mercier, Benjamin; Nally, Elizabeth; Ali, Adil; Hutson, Thomas E.; Bex, Axel; Psutka, Sarah P.; Rini, Brian; Plimack, Elizabeth; Master, Viraj A.; Grunwald, Viktor; Albiges, Laurence; Choueri, Toni; Pal, Sumanta; Cella, David; Powles, Thomas; Bergerot, Cristiane Decat Share Save
Real-World efficacy and safety of belzutifan in sporadic metastatic renal cell carcinoma: a multicenter study from the city of hope enterprise Nguyen, Charles; Nguyen, Kim; Ebrahimi, Hedyeh; Zugman, Miguel; Zang, Peter; Pisick, Evan; Kollimuttathuillam, Sudarsan; Mehta, Nilesh; Liu, Sandy; Tripathi, Abhishek; Chehrazi-Raffle, Alexander; Adesunloye, Bamidele; Bryce, Alan; Dorff, Tanya; Pal, Sumanta Share Save
Lower checkpoint gene expression is associated with primary resistance to nivolumab-ipilimumab combination in advanced renal cell carcinoma McKay, Rana; Dugan, Adam; Jariwala, Unnati; Ronski, Karyn; Mercer, Jacob; Saad, Eddy; El Masri, Jad; Machaalani, Marc; Saleh, Mustafa; Rose, Cody; Sun, Maxine; Signoretti, Sabina; Braun, David; Pal, Sumanta; Choueri, Toni Share Save
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma Mercier, Benjamin; Govindarajan, Ameish; Hansen, Nathaniel; Byron, Sara; Hegde, Apurva; Leskoske, Kristin; Chawla, Neal; Meza, Luis; Zengin, Zeynep; Barragan-Carrillo, Regina; Ebrahimi, Hedyeh; Castro, Daniela; Jaime-Casas, Salvador; Zugman, Miguel; Dizman, Nazli; Hsu, JoAnn; Chehrazi-Raffle, Alexander; Tripathi, Abhishek; Salgia, Nicholas; Pal, Sumanta; Pirrotte, Patrick Share Save
Share Save
Clinical characteristics, determinants and subsequent therapy of primary refractory metastatic renal cell carcinoma (mRCC): an international metastatic database consortium (IMDC) study Eid, Marc; Semaan, Karl; Xie, Wanling; Chehade, Razane El Hajj; Ascione, Liliana; Maj, David; Zarba, Martin; Wells, J. Connor; Wood, Laura; Tran, Ben; Angel, Martin; Pal, Sumanta K.; Lee, Jae-Lyun; Takemura, Kosuke; Kollmannsberger, Christian K.; Templeton, Arnoud J.; Bjarnason, Georg A.; Ruiz, Jose Manuel; Heng, Daniel; Choueiri, Toni K. Share Save
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab-Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Lemelin, Audreylie; Maj, David; Takemura, Kosuke; Boyne, Devon J.; Warkentin, Matthew T.; Brenner, Darren R.; Cheung, Winson Y.; Wells, Connor; Labaki, Chris; Mcgregor, Bradley A.; Contreras, Luis Meza; Pal, Sumanta K.; Beuselinck, Benoit; Mckay, Rana R.; Szabados, Bernadett; Powles, Thomas; Yuasa, Takeshi; Ludwig, Lisa; Choueiri, Toni K.; Heng, Daniel Y. C. Share Save
Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials Zugman, Miguel; Rider, Jennifer R.; Dizman, Nazli; Jaime-Casas, Salvador; Goes, Vitor Abreu; Shah, Koral; Castro, Daniela, V; Mercier, Benjamin; Zang, Peter; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Sahu, Diwyanshu; Mandora, Prithviraj Vikramsinh; Hsu, Joann; Yip, Wesley; Nguyen, Charles B.; Chehrazi-Raffle, Alex; Miller, Robert; Powles, Thomas; Choueiri, Toni; Pal, Sumanta K. Share Save
Characterizing carbonic anhydrase 9 and HIF-2α RNA expression in clear cell renal cell carcinoma (ccRCC) Chen, Yu-Wei; Nazari, Shayan; Elliott, Andrew; Kulkami, Ninad; Smith, Norm; Nawfal, Rashad; Barata, Pedro C.; Bagrodia, Aditya; Rose, Brent; McDermott, David; Signoretti, Sabina; Machaalani, Marc; Shiva, Shankar; Hofman, Michael; Agarwal, Neeraj; Pal, Sumanta; Choueri, Toni; Mckay, Rana Share Save
Overview of tivozanib (tivo) safety in phase 3 clinical trials in patients with metastatic renal cell carcinoma (mRCC) Barata, Pedro C.; Rini, Brian; Choueri, Toni; Pal, Sumanta; Barthelemy, Philippe; Iacovelli, Roberto; Mcgregor, Bradley A.; Albiges, Laurence; Molina-Cerrillo, Javier; Garmezy, Benjamin; Hauke, Ralph; Tejwani, Sheela; Basu, Arnab; Moon, Helen; Beckermann, Katy; Ornstein, Moshe; Mckay, Rana; Lebedinsky, Claudia; Braendle, Edgar E.; Motzer, Robert Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
